YUNICAP
Technology platformCombination formulation joining soft capsules and pellets; a benign prostatic hyperplasia combination using it targets launch in the second half of 2027.
FROM PUBLIC EVENTS · 2026-11-15
Discovery · preclinical Preparing its next products with a new combination-formulation technology and companion-animal drug development. Also seen: Commercial · sales
Roles often seen at this stageResearch & development · Manufacturing & MSAT
A maker of prescription and over-the-counter medicines, newly developing a combination-formulation platform and new drugs for companion animals.
Combination formulation joining soft capsules and pellets; a benign prostatic hyperplasia combination using it targets launch in the second half of 2027.
Nasal-care range that added three new products to make four.
Developed the YUNICAP combination-formulation platform and set up its manufacturing process at the Jecheon plant.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.